Kesselheim AS - Search Results

1

The Safety of Prescription Drugs.

Sharfstein JM, Kesselheim AS. Sharfstein JM, et al. Among authors: kesselheim as. JAMA. 2015 Jul 21;314(3):233-4. doi: 10.1001/jama.2015.7151. JAMA. 2015. PMID: 26197182 No abstract available.

2

University-based science and biotechnology products: defining the boundaries of intellectual property.

Kesselheim AS, Avorn J. Kesselheim AS, et al. JAMA. 2005 Feb 16;293(7):850-4. doi: 10.1001/jama.293.7.850. JAMA. 2005. PMID: 15713775

3

Biomedical patents and the public's health: is there a role for eminent domain?

Kesselheim AS, Avorn J. Kesselheim AS, et al. JAMA. 2006 Jan 25;295(4):434-7. doi: 10.1001/jama.295.4.434. JAMA. 2006. PMID: 16434634 No abstract available.

4

Will physician-level measures of clinical performance be used in medical malpractice litigation?

Kesselheim AS, Ferris TG, Studdert DM. Kesselheim AS, et al. JAMA. 2006 Apr 19;295(15):1831-4. doi: 10.1001/jama.295.15.1831. JAMA. 2006. PMID: 16622145 No abstract available.

5

The role of litigation in defining drug risks.

Kesselheim AS, Avorn J. Kesselheim AS, et al. JAMA. 2007 Jan 17;297(3):308-11. doi: 10.1001/jama.297.3.308. JAMA. 2007. PMID: 17227983 No abstract available.

6

Confidentiality laws and secrecy in medical research: improving public access to data on drug safety.

Kesselheim AS, Mello MM. Kesselheim AS, et al. Health Aff (Millwood). 2007 Mar-Apr;26(2):483-91. doi: 10.1377/hlthaff.26.2.483. Health Aff (Millwood). 2007. PMID: 17339677 Review.

7

Role of professional organizations in regulating physician expert witness testimony.

Kesselheim AS, Studdert DM. Kesselheim AS, et al. JAMA. 2007 Dec 26;298(24):2907-9. doi: 10.1001/jama.298.24.2907. JAMA. 2007. PMID: 18159060 No abstract available.

8

Scientific and legal viability of follow-on protein drugs.

Dudzinski DM, Kesselheim AS. Dudzinski DM, et al. Among authors: kesselheim as. N Engl J Med. 2008 Feb 21;358(8):843-9. doi: 10.1056/NEJMhle0706973. N Engl J Med. 2008. PMID: 18287608 No abstract available.

9

The international pharmaceutical market as a source of low-cost prescription drugs for U.S. patients.

Kesselheim AS, Choudhry NK. Kesselheim AS, et al. Ann Intern Med. 2008 Apr 15;148(8):614-9. doi: 10.7326/0003-4819-148-8-200804150-00006. Ann Intern Med. 2008. PMID: 18413623

10

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, Shrank WH. Kesselheim AS, et al. JAMA. 2008 Dec 3;300(21):2514-26. doi: 10.1001/jama.2008.758. JAMA. 2008. PMID: 19050195 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results